Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:15 pm Purchase | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | Lind Global Fund II LP | 16,117 0.400% | 16,117 (New Position) | Filing History |
| 2024-11-14 3:40 pm Purchase | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | Armistice Capital, LLC | 270,000 7.120% | 270,000 (New Position) | Filing History |
| 2024-11-14 08:53 am Unchanged | 2024-09-30 | 13G | Windtree Therapeutics, Inc. WINT | James E. Flynn | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:30 pm Sale | 2023-12-31 | 13G | Windtree Therapeutics, Inc. WINT | Lincoln Park Capital Fund LLC | 18,843 6.181% | -6,660 (-26.11%) | Filing History |
| 2024-02-13 8:15 pm Sale | 2023-12-31 | 13G | Windtree Therapeutics, Inc. WINT | Lind Global Fund II LP | 16,117 5.300% | -10,278 (-38.94%) | Filing History |
| 2024-02-01 5:26 pm Purchase | 2024-01-24 | 13G | Windtree Therapeutics, Inc. WINT | James E. Flynn | 33,793 7.590% | 33,793 (New Position) | Filing History |
| 2023-11-13 11:41 am Purchase | 2023-10-09 | 13G | Windtree Therapeutics, Inc. WINT | Duvvuri Krishna | 18,161 6.350% | 18,161 (New Position) | Filing History |
| 2023-05-17 07:30 am Purchase | 2023-05-17 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 4,200 1.500% | 4,200 (New Position) | Filing History |
| 2023-04-28 4:42 pm Purchase | 2023-04-24 | 13G | Windtree Therapeutics, Inc. WINT | Lind Global Fund II LP | 26,395 9.900% | 26,395 (New Position) | Filing History |
| 2023-04-24 4:33 pm Purchase | 2023-04-20 | 13G | Windtree Therapeutics, Inc. WINT | Lincoln Park Capital Fund LLC | 25,502 9.990% | 25,502 (New Position) | Filing History |
| 2023-04-19 07:14 am Sale | 2023-04-18 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 0 0.000% | -4,200 (Position Closed) | Filing History |
| 2023-02-23 4:31 pm Unchanged | 2023-02-22 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 4,200 8.700% | 0 (Unchanged) | Filing History |
| 2023-02-08 7:49 pm Purchase | 2023-01-30 | 13D | Windtree Therapeutics, Inc. WINT | Huang James | 4,200 8.600% | 4,200 (New Position) | Filing History |
| 2022-01-10 3:27 pm Purchase | 2021-12-30 | 13G | Windtree Therapeutics, Inc. WINT | Center Laboratories Inc. | 1,715 5.400% | 399 (+30.35%) | Filing History |